Zobrazeno 1 - 10
of 640
pro vyhledávání: '"Mei Di"'
Autor:
Siva Charan Devanaboyina, Peng Li, Edward L. LaGory, Carrie Poon-Andersen, Kevin D. Cook, Marcus Soto, Zhe Wang, Khue Dang, Craig Uyeda, Ryan B. Case, Veena A. Thomas, Ronya Primack, Manuel Ponce, Mei Di, Brian Ouyang, Joelle Kaner, Sheung Kwan Lam, Mina Mostafavi
Publikováno v:
mAbs, Vol 16, Iss 1 (2024)
Targeting antigens with antibodies exhibiting pH/Ca2+-dependent binding against an antigen is an attractive strategy to mitigate target-mediated disposition and antigen buffering. Studies have reported improved serum exposure of antibodies exhibiting
Externí odkaz:
https://doaj.org/article/e01cdf9351b64b009ab7296a2022f247
Publikováno v:
Security and Safety, Vol 2, p 2023029 (2023)
With the expanding applications of multiple unmanned systems in various fields, more and more research attention has been paid to their security. The aim is to enhance the anti-interference ability, ensure their reliability and stability, and better
Externí odkaz:
https://doaj.org/article/228b67fb21d04643b6eab673dc6a57df
Autor:
Frederick J. Raal, Robert P. Giugliano, Marc S. Sabatine, Michael J. Koren, Dirk Blom, Nabil G. Seidah, Narimon Honarpour, Armando Lira, Allen Xue, Padmaja Chiruvolu, Simon Jackson, Mei Di, Matthew Peach, Ransi Somaratne, Scott M. Wasserman, Rob Scott, Evan A. Stein
Publikováno v:
Journal of Lipid Research, Vol 57, Iss 6, Pp 1086-1096 (2016)
Lipoprotein (a) [Lp(a)] is independently associated with CVD risk. Evolocumab, a monoclonal antibody (mAb) to proprotein convertase subtilisin/kexin type 9 (PCSK9), decreases Lp(a). The potential mechanisms were assessed. A pooled analysis of Lp(a) a
Externí odkaz:
https://doaj.org/article/9354fcf031054b99ad4b43fb63db33b0
Autor:
Brandon Ason, José W.A. van der Hoorn, Joyce Chan, Edward Lee, Elsbet J. Pieterman, Kathy Khanh Nguyen, Mei Di, Susan Shetterly, Jie Tang, Wen-Chen Yeh, Margrit Schwarz, J. Wouter Jukema, Rob Scott, Scott M. Wasserman, Hans M.G. Princen, Simon Jackson
Publikováno v:
Journal of Lipid Research, Vol 55, Iss 11, Pp 2370-2379 (2014)
LDL cholesterol (LDL-C) contributes to coronary heart disease. Proprotein convertase subtilisin/kexin type 9 (PCSK9) increases LDL-C by inhibiting LDL-C clearance. The therapeutic potential for PCSK9 inhibitors is highlighted by the fact that PCSK9 l
Externí odkaz:
https://doaj.org/article/a47428822d15485fadea23f4fd960402
Autor:
Shen, Mei-di1 (AUTHOR), Gao, Rui-tong2 (AUTHOR), Chen, Si-bing3 (AUTHOR), Xu, Zhong-hang4 (AUTHOR) xzh20@mails.jlu.edu.cn, Ding, Xiang-dong3 (AUTHOR) dingxd21@mails.jlu.edu.cn
Publikováno v:
BMC Pregnancy & Childbirth. 9/6/2024, Vol. 24 Issue 1, p1-13. 13p.
Publikováno v:
In Sustainable Cities and Society 1 November 2024 114
Autor:
Chen, Dongfang, Mei, Di, Chen, Lan, Wang, Cheng, Bai, Jing, Xue, Feng, Chu, Chenglin, Wang, Liguo, Zhu, Shijie, Guan, Shaokang
Publikováno v:
In Applied Surface Science 1 November 2024 672
Autor:
Li, Youqing, Hou, Ruiqing, Jiang, Pingli, Li, Ke, Wang, Jun, Mei, Di, Wu, Lihong, Zhu, Shijie, Willumeit-Rőmer, Regine, Guan, Shaokang
Publikováno v:
In Corrosion Science October 2024 239
Autor:
Mei, Di, Zhang, Qingyuan, Li, Yaqian, Liu, Mengyao, Li, Wenkai, Jiang, Pingli, Hou, Ruiqing, Zhu, Shijie, Wang, Liguo, Guan, Shaokang
Publikováno v:
In Journal of Magnesium and Alloys September 2024 12(9):3661-3674
Publikováno v:
In International Journal of Heat and Mass Transfer 1 September 2024 229